RH (NYSE:RH) Reports Q3 CY2025 In Line With Expectations, Stock Soars

RH reported Q3 CY2025 revenue of $883.8 million, up 8.9% year-on-year and essentially in line with expectations, but delivered an adjusted EPS of $1.71 that missed consensus by 20.9% and posted adjusted EBITDA of $155.8 million below estimates; management guided Q4 revenue to a $873.3 million midpoint, about 2.5% below Street, and flagged a 370 basis-point headwind to margins from international expansion and tariffs (adj. operating margin midpoint 13%). Free cash flow turned positive at $83.0 million versus negative $96.0 million a year earlier and operating margin held at 12%, leaving a mixed read: top-line momentum and cash conversion are improving, but near-term profitability and execution on expansion/tariff pressures will determine whether the company can meet sell-side expectations for accelerated revenue growth over the next 12 months.

Analysis

RH reported Q3 CY2025 revenue of $883.8 million, up 8.9% year‑over‑year and essentially in line with the $883.5 million Street estimate, while adjusted EPS of $1.71 missed consensus by 20.9% ($2.16 expected) and adjusted EBITDA of $155.8 million fell short of the $165.5 million estimate (17.6% margin). Operating margin held at 12% versus the prior year and free cash flow swung to a positive $83.03 million from negative $95.99 million a year earlier, indicating materially improved cash conversion despite the profit miss.

Management guided Q4 revenue to a $873.3 million midpoint, roughly 2.5% below the $896.2 million analyst consensus, and set adjusted operating margin guidance at a 13.0% midpoint that explicitly includes a 370 basis‑point headwind from international expansion and tariffs; management is targeting ~7.5% year‑over‑year sales growth next quarter while sell‑side models expect ~10.3% revenue growth over the next 12 months. The guidance implies near‑term margin pressure tied to expansion and trade costs and leaves execution on new product/licensing initiatives as the key driver for the projected revenue acceleration.

The print is a mixed operational read: revenue momentum and a strong cash‑flow recovery contrast with meaningful EPS and EBITDA misses and explicit macro/expansion headwinds that compress near‑term profitability. Key risks for the investment case are execution on international rollout and tariff mitigation, the company’s relatively small scale ($2.95 billion market cap) versus larger competitors, and whether future quarters deliver the margin normalization embedded in sell‑side expectations.

Key Decisions for Investors

• It may be prudent to adopt a cautious hold posture until RH’s Q4 results demonstrate revenue and EBITDA at or above guidance and the company quantifies progress offsetting the 370bps tariff/expansion headwind
• Consider increasing conviction only if successive quarters show margin recovery and continued positive free cash flow, since FCF turned to +$83.03 million this quarter and is the clearest sign of financial improvement
• Limit position size or use hedges given RH’s small market capitalization and execution risk from international expansion, monitor same‑store trends and management commentary on tariff pass‑through and new product traction